Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Chem Pharm Bull (Tokyo) ; 58(11): 1461-5, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21048337

RESUMEN

The objective of this work was to develop a safe and effective delivery vehicle for topical treatment of gemcitabine. The physicochemical properties, drug release rate, drug level in plasma and bladder, and histological changes of tissue after drug administration were investigated. The electrical conductivity, mean size, and viscosity of drug-loaded microemulsions were 0.8-102.0 µS/cm, 116.8-322.5 nm, and 42.9-105.0 cps×10³, respectively. Gemcitabine loaded microemulsions showed a slower and sustained release. After intravesical administration of aqueous control and microemulsions treated, the drug concentrations in plasma were 15.11 µg/ml and 2.81-12.82 µg/ml, respectively, and the accumulation in bladder were 18.27 µg and 9.12-64.16 µg, respectively. Microemulsions slightly decreased the systemic absorption and significantly enhanced the accumulation in bladder tissue. Moreover, the preliminary toxicity studies revealed no overt adverse histological changes or tissue irritation by the microemulsion application. Therefore, the microemulsions were suggested to be a promising drug carrier for intravesical chemotherapy.


Asunto(s)
Antimetabolitos Antineoplásicos/administración & dosificación , Antimetabolitos Antineoplásicos/farmacocinética , Desoxicitidina/análogos & derivados , Portadores de Fármacos/química , Vejiga Urinaria/metabolismo , Administración Intravesical , Animales , Antimetabolitos Antineoplásicos/sangre , Desoxicitidina/administración & dosificación , Desoxicitidina/sangre , Desoxicitidina/farmacocinética , Emulsiones/química , Femenino , Humanos , Ratas , Ratas Sprague-Dawley , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico , Gemcitabina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA